Imaging Alzheimer's amyloid
- 1 August 2000
- journal article
- editorial
- Published by Springer Nature in Nature Biotechnology
- Vol. 18 (8) , 823-824
- https://doi.org/10.1038/78422
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Targeting Alzheimer amyloid plaques in vivoNature Biotechnology, 2000
- Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1Nature Cell Biology, 2000
- Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1Nature, 2000
- Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive DeclineJAMA, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995
- Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.Proceedings of the National Academy of Sciences, 1992